No Data
Norwalk (688105.SH): Cumulatively repurchased 1.08% of the company's shares.
On November 1, GeLonghui reported that as of October 31, 2024, Nouweizan (688105.SH) announced that the company repurchased a total of 4,301,724 shares of the company through the Shanghai Stock Exchange system through centralized auction trading, accounting for 1.08% of the total share capital of 400,010,000 shares. The lowest price for repurchase transactions was 17.65 yuan/share and the highest price was 28.65 yuan/share. The total payment amount was 104,011,578.16 yuan (excluding transaction costs).
Novi Zam: third quarter report 2024
Third Quarter Report 2024
zheshang: Continuous realization of technological innovation upgrade driving the continuous improvement of performance expectations for innovative drugs and industry chain.
The commercialization period of innovative drugs in the industry chain, driven purely by incremental value, is entering the phase of realization. The scarce incremental prosperity of the pharmaceutical sector continues to rise, with increasing international competitiveness, and there is still room for upward valuation.
Subdued Growth No Barrier To Nanjing Vazyme Biotech Co., Ltd (SHSE:688105) With Shares Advancing 45%
Vazyme Leads Life Science Innovation, Boosting Research Breakthroughs in MIDH1 Cancer Treatment
Investors Don't See Light At End Of Nanjing Vazyme Biotech Co.,Ltd's (SHSE:688105) Tunnel And Push Stock Down 27%No Data
No Data
